Can you help me with how I get a second opinion? I am in BC Canada and very close to Vancouver. Can you share the...

Second Opinion & Treatment Decision Support

I understand this is urgent—your oncologist wants to make a significant treatment change, and you're rightfully wanting to explore all options. Let me address both your immediate questions.

GETTING A SECOND OPINION IN BC/VANCOUVER

Steps to Take RIGHT NOW:

1. **Request Your [ID removed]

   • Contact your current oncology clinic and request a formal records transfer
   • Ask specifically for: pathology reports, imaging reports (including your recent PET), genomic testing results, treatment history with response assessments, and all imaging studies
   • This typically takes 3-5 business days

2. BC Cancer Second Opinion Process

   • BC Cancer (Provincial Authority): Call 1-[phone removed] or visit www.bccancer.bc.ca
   • Ask for "second opinion consultation" - BC Cancer has formal pathways for this
   • You can request a specific oncologist or let them match you based on your cancer type
   • Vancouver location: BC Cancer - Vancouver Centre (600 West 10th Ave)

3. Alternative: University of British Columbia (UBC)

   • UBC Department of Medicine, Division of Oncology: (604) 875-4111
   • UBC Oncology often provides second opinions and has expertise in complex GI cancers
   • Ask to speak with the GI oncology team specifically

4. Timeline Consideration

   • Second opinions typically take 1-2 weeks to arrange
   • You can request a brief treatment pause while awaiting the second opinion—this is a reasonable request given the significance of moving to 5th-line therapy

---

ABOUT THE CAPOX → TRIFLURIDINE DECISION

Understanding Your Current Situation:

Your genomic testing shows several important findings:

• HRD signature positive (homologous recombination deficiency) - this is clinically significant
• BRCA1 mutation (Q1756fs*74) - a pathogenic variant
• Microsatellite stable (not MSI-high)
• Multiple tumor suppressor losses (CDKN2A, CDKN2B, MTAP, NF1)

Your PET scan shows widespread progression with new FDG-avid lesions, indicating the cancer is advancing despite CAPOX.

How Oncologists Think About This Decision:

When a patient with metastatic duodenal cancer progresses on CAPOX (a standard first-line chemotherapy), oncologists typically consider:

1. Chemotherapy options (trifluridine/tipiracil is an FDA-approved option for advanced GI cancers after prior fluoropyrimidine therapy)
2. Targeted therapy based on genomics - your BRCA1 mutation and HRD signature may open specific pathways
3. Clinical trial eligibility - particularly important at 5th-line given your specific mutations
4. Palliative care integration - ensuring quality of life discussions happen alongside treatment decisions

What the Medical Literature Shows:

According to NCCN Guidelines for Gastric Cancer (duodenal cancers follow similar pathways), treatment decisions at progression typically involve:

• Reassessing performance status and organ function
• Considering whether genomic findings suggest targeted approaches
• Evaluating clinical trial options, especially for patients with specific mutations like yours
• Discussing goals of care explicitly

---

CRITICAL QUESTIONS TO ASK BEFORE STOPPING CAPOX

Before you agree to switch, ask your oncologist:

1. "Given my HRD signature positive status and BRCA1 mutation, have we explored PARP inhibitor options? Are there clinical trials using PARP inhibitors for my specific mutation profile?"

   • Why this matters: HRD-positive tumors may respond to PARP inhibitors; this is worth exploring before moving to chemotherapy

2. "What is the evidence for trifluridine in duodenal cancer specifically, and what response rates should I expect?"

   • Why this matters: Understanding realistic outcomes helps you make an informed decision

3. "Are there any clinical trials I'm eligible for given my genomic profile? Should we check ClinicalTrials.gov or contact specialized centers?"

   • Why this matters: At 5th-line, trials may offer options not available in standard care

4. "Can we pause treatment for 1-2 weeks while I get a second opinion? What are the risks of a brief delay?"

   • Why this matters: This is reasonable and allows you to make a fully informed decision

5. "What are your goals for this next treatment—are we aiming for response, disease stabilization, or symptom management?"

   • Why this matters: This clarifies expectations and helps align treatment with your values

---

WHAT TO DO RIGHT NOW (Action Plan)

TODAY/TOMORROW:

• ✅ Call BC Cancer (1-[phone removed]) and request second opinion consultation
• ✅ Request your [ID removed] be prepared for transfer
• ✅ Ask your current oncologist if treatment can be paused 1-2 weeks for second opinion

THIS WEEK:

• ✅ Provide your records to the second opinion oncologist
• ✅ Prepare a list of questions (use the ones above)
• ✅ Research your specific mutations on ClinicalTrials.gov (filter for duodenal cancer + BRCA1 or HRD)

BEFORE DECIDING ON TRIFLURIDINE:

• ✅ Get the second opinion
• ✅ Ask specifically about PARP inhibitor eligibility given your HRD/BRCA1 status
• ✅ Understand realistic response expectations

---

IMPORTANT CONTEXT

Your genomic profile is actually quite informative—the BRCA1 mutation and HRD signature suggest you may have options beyond standard chemotherapy. This is exactly the kind of situation where a second opinion from a specialized GI oncology center (like UBC or BC Cancer's GI team) can be valuable.

You are not being unreasonable to ask for a brief pause and second opinion. This is standard practice in oncology, especially when moving to 5th-line therapy.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Gastric Cancer; American Cancer Society; ClinicalTrials.gov; BC Cancer Provincial Authority